Related Experiment Videos
[Chylous effusions]
Ilija Tomić1, Goran Plavec, Vukojica Karlicić
1Vojnomedicinska akademija, Klinika za plućne bolesti, Beograd.
Vojnosanitetski Pregled
|November 12, 2003
Summary
This study details five cases of chylous effusions, including chylothorax and chyloperitoneum, stemming from tuberculosis, vertebral fracture, or idiopathic causes. All patients achieved successful treatment outcomes through various interventions.
Area of Science:
- Medicine
- Pulmonology
- Gastroenterology
Background:
- Chylous effusions, such as chylothorax and chyloperitoneum, can arise from diverse etiologies, including infections, trauma, and idiopathic conditions.
- Accurate diagnosis relies on identifying chylomicrons and elevated triglyceride levels in the effusion fluid.
Observation:
- This case series describes five patients presenting with chylous effusions: four with chylothorax and one with bilateral chylothorax and chyloperitoneum.
- The effusions were attributed to miliary tuberculosis, an L-2 vertebral body fracture, or were idiopathic in origin.
- Diagnostic lymphangiography revealed lymphatic system abnormalities but did not pinpoint the exact site of leakage.
Findings:
- Biochemical analysis confirmed chylous effusions with triglyceride levels ranging from 11.9 to 29.1 mmol/l.
- Treatment modalities included prolonged drainage with total parenteral nutrition, pleurodesis with Corynebacterium parvum, and surgical partial parietal pleurectomy.
- All presented cases demonstrated successful treatment outcomes regardless of the chosen intervention.
Implications:
- These findings highlight the varied etiologies and successful management strategies for chylous effusions.
- The study underscores the importance of prompt diagnosis and tailored treatment approaches for benign chylous effusions.
- Effective management can be achieved through conservative measures, chemical pleurodesis, or surgical intervention, leading to favorable patient outcomes.